These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 16596499)
21. Economic analysis of a randomized trial of biventricular pacing in Canada. Bentkover JD; Dorian P; Thibault B; Gardner M Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313 [TBL] [Abstract][Full Text] [Related]
22. Cardiac-resynchronization therapy. Wilson JR N Engl J Med; 2010 Jan; 362(2):178; author reply 179. PubMed ID: 20077591 [No Abstract] [Full Text] [Related]
23. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report]. Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244 [TBL] [Abstract][Full Text] [Related]
24. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Grimm W; Plachta E; Maisch B Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513 [TBL] [Abstract][Full Text] [Related]
25. [Resynchronization therapy for heart insufficiency]. Butter C Dtsch Med Wochenschr; 2006 Sep; 131(39):2153-7. PubMed ID: 16991031 [No Abstract] [Full Text] [Related]
27. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
29. [Cardiac resynchronization therapy: are all questions answered?]. Auricchio A Herzschrittmacherther Elektrophysiol; 2005 Mar; 16(1):1-2. PubMed ID: 15824869 [No Abstract] [Full Text] [Related]
30. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447 [TBL] [Abstract][Full Text] [Related]
31. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
32. Left ventricular endocardial pacing improves the clinical efficacy in a non-responder to cardiac resynchronization therapy: role of acute haemodynamic testing. Bracke FA; Houthuizen P; Rahel BM; van Gelder BM Europace; 2010 Jul; 12(7):1032-4. PubMed ID: 20200018 [No Abstract] [Full Text] [Related]
33. A novel cardiac MRI protocol to guide successful cardiac resynchronization therapy implantation. Duckett SG; Ginks M; Knowles BR; Chiribiri A; Ma YL; Razavi R; Schaeffter T; Carr-White G; Rinaldi CA; Rhode K Circ Heart Fail; 2010 Jul; 3(4):e18-21. PubMed ID: 20647480 [No Abstract] [Full Text] [Related]
34. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Klein MH; Gold MR Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188 [TBL] [Abstract][Full Text] [Related]